100 related articles for article (PubMed ID: 2578698)
1. Protective effects of human gamma-globulin preparations against experimental aerosol infections of mice with Bordetella pertussis.
Imaizumi A; Suzuki Y; Sato H; Sato Y
Vox Sang; 1985; 48(1):18-25. PubMed ID: 2578698
[TBL] [Abstract][Full Text] [Related]
2. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
3. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
5. [Protective effects of human gamma globulin preparations against experimental aerosol infections of mice with Bordetella pertussis].
Imaizumi A; Suzuki Y; Sato Y
Kansenshogaku Zasshi; 1984 Jun; 58(6):518-24. PubMed ID: 6092492
[No Abstract] [Full Text] [Related]
6. [Determination of protective effect of normal and antipertussis gamma globulin and model infections with Hemophilus pertussis in animals].
DEMELOVA M; HOUBA V; MAZACEK M
Cesk Pediatr; 1956 Sep; 11(9):669-74. PubMed ID: 13383686
[No Abstract] [Full Text] [Related]
7. Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.
Tomioka H; Iwamura Y; Suzuki Y; Ohtomo S; Hashimoto Y
Infect Immun; 1980 Nov; 30(2):329-36. PubMed ID: 6160106
[TBL] [Abstract][Full Text] [Related]
8. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
10. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies.
Sato H; Sato Y; Ohishi I
Infect Immun; 1991 Oct; 59(10):3832-5. PubMed ID: 1894382
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
Kamachi K; Konda T; Arakawa Y
Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.
Leef M; Elkins KL; Barbic J; Shahin RD
J Exp Med; 2000 Jun; 191(11):1841-52. PubMed ID: 10839801
[TBL] [Abstract][Full Text] [Related]
14. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
15. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
[TBL] [Abstract][Full Text] [Related]
16. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
Hormozi K; Parton R; Coote J
FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
19. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.
Kobayashi N; Gohya N; Matsumoto S
Eur J Pediatr; 1981 May; 136(2):159-65. PubMed ID: 6164554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
